Lv4
490 积分 2024-01-15 加入
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
1小时前
已完结
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
2小时前
已完结
The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseases
12天前
已完结
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies
12天前
已完结
Noncoding RNAs associated with IgA nephropathy
3个月前
已完结
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
10个月前
已完结
Long-Term Outcomes in IgA Nephropathy
10个月前
已完结
皖公网安备34019202002308
